Previous 10 | Next 10 |
2023-09-05 10:00:14 ET More on Health Care Select Sector SPDR Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Dividend scorecard for Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) ...
LEXINGTON, Mass. and AMSTERDAM, Sept. 05, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigat...
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , Se...
2023-09-01 18:33:42 ET More on Airbnb and Blackstone Airbnb: Upgrading To Hold, Headwinds Priced In How To Think About Airbnb Blackstone: Load Up Before It Recovers Its All-Time Highs (Rating Upgrade) Blackstone: Time For A Rating Downgrade Airbnb: Ev...
2023-08-01 08:01:18 ET uniQure press release ( NASDAQ: QURE ): Q2 EPS of -$1.44 may not be comparable to consensus of $2.72. Revenue of $2.4M (+380.0% Y/Y). Revenue for the three months ended June 30, 2023 was $2.4 million, compared to $0.5 million in the same period i...
~ Announced encouraging interim analysis data from ongoing Phase I/II clinical trial of AMT-130 in Huntington’s disease showing preservation of function compared to baseline and clinical benefits relative to natural history; both dose cohorts of AMT-130 continue to be generally well-tolera...
2023-07-17 13:47:20 ET Summary AMT-130, a gene therapy designed to inhibit the production of mutant huntingtin protein, has shown perplexing results in trials. The safety profile of AMT-130 is acceptable and further data is expected in Q4. Despite the confusing data, there are...
LEXINGTON, Mass. and AMSTERDAM, June 26, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Walid Abi-Saab, M.D., as Chief Medical Officer, effective...
2023-06-22 15:03:58 ET Shares of gene therapy specialist uniQure (NASDAQ: QURE) fell by 42% during the first three and a half days of trading this week, according to data provided by S&P Global Market Intelligence . The stock's big weekly loss stems from a mixed interim anal...
2023-06-21 13:20:27 ET Gainers: Argo Blockchain ( ARBK ) +32% . Ocean Biomedical ( OCEA ) +21% . Mullen Automotive ( MULN ) +20% . Freightos Limited ( CRGO ) +18% . PureCycle Technologies ( PCT ) +17% . PetVivo Holdings ( P...
News, Short Squeeze, Breakout and More Instantly...
~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene therapy candidates ~ ~ Immediate reduction in cash burn, projected to save $40 million annually ~ LEXINGTON, Mass. and AMSTERDAM, July 23, 2024 (GLOBE NEWSWIRE) -...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 2.5% to $131.38 on volume of 280,159,738 shares Maxeon Solar Technologies Ltd. (MAXN) fell 8.1% to $0.248 on volume of 217,585,873 shares Tesla Inc. (TSLA) rose 3.7% to $262.33 on volume of 159,323,492 s...